Jefferies Downgrades Wal-Mart (WMT) to Hold On Lower Estimates
Get Alerts WMT Hot Sheet
Price: $59.94 +1.44%
Rating Summary:
38 Buy, 12 Hold, 3 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
38 Buy, 12 Hold, 3 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Jefferies downgraded Wal-Mart (NYSE: WMT) from Buy to Hold with a price target of $56 (from $61).
The firm cut FY12 and FY13 EPS estimates to $4.43 and $4.71 from $4.52 and $4.95, respectively.
Jefferies' analyst said, "Recent market share data suggests continued challenges at Wal-Mart in Q2, which combined with our own checks, lead us to think there is downside risk to sales in Q2 and potentially over the balance of the year."
The firm also note that Wal-Mart could get more aggressive on pricing, which raises the risk of greater than expected gross margin erosion in future quarters. Also inflation in food and fuel could pressure sales mix and margins further.
For more ratings news on Wal-Mart click here and for the rating history of Wal-Mart click here.
Shares of Wal-Mart closed at $52.62 yesterday.
The firm cut FY12 and FY13 EPS estimates to $4.43 and $4.71 from $4.52 and $4.95, respectively.
Jefferies' analyst said, "Recent market share data suggests continued challenges at Wal-Mart in Q2, which combined with our own checks, lead us to think there is downside risk to sales in Q2 and potentially over the balance of the year."
The firm also note that Wal-Mart could get more aggressive on pricing, which raises the risk of greater than expected gross margin erosion in future quarters. Also inflation in food and fuel could pressure sales mix and margins further.
For more ratings news on Wal-Mart click here and for the rating history of Wal-Mart click here.
Shares of Wal-Mart closed at $52.62 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Downgrades Molson Coors (TAP) to Sell, 'Cycling 2023 Could Be a Mountain Too Hard to Climb'
- Neurocrine Bio. (NBIX) PT Raised to $182 at Jefferies
- JPMorgan Downgrades Five Below (FIVE) to Neutral
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!